PolyIC Induces Retinoic Acid-inducible Gene-I and Melanoma Differentiation-associated Gene 5 and Modulates Inflammation in Podocytes.


Journal

In vivo (Athens, Greece)
ISSN: 1791-7549
Titre abrégé: In Vivo
Pays: Greece
ID NLM: 8806809

Informations de publication

Date de publication:
Historique:
received: 30 09 2020
revised: 12 10 2020
accepted: 13 10 2020
entrez: 6 1 2021
pubmed: 7 1 2021
medline: 22 6 2021
Statut: ppublish

Résumé

Viral infection often exacerbates proteinuria, which has been suggested to be due to antiviral responses of podocytes. We examined the effect of polyinosinic-polycytidylic acid (polyIC) on the expression of retinoic acid-inducible gene-I (RIG-I) and melanoma differentiation-associated gene 5 (MDA5) in differentiated human podocytes in culture. The podocytes were treated with 2 ng/ml to 500 μg/ml of polyIC for 3 to 36 h, and also transfected with siRNA against RIG-I and MDA5. F-actin staining was performed to assess actin reorganization. PolyIC induced the expression of RIG-I and MDA5 in dose- and time-dependent manner, accompanied with interferon-β (IFN-β) and interleukin-6 (IL-6) up-regulation and actin reorganization. Temporal knockdown of RIG-I by siRNA decreased IFN-β expression, while MDA5 siRNA inhibited IFN-β and IL-6 expression. Actin reorganization was attenuated by RIG-I and MDA5 knockdown. RIG-I and MDA5 may play a role in the antiviral responses of podocytes.

Sections du résumé

BACKGROUND/AIM OBJECTIVE
Viral infection often exacerbates proteinuria, which has been suggested to be due to antiviral responses of podocytes. We examined the effect of polyinosinic-polycytidylic acid (polyIC) on the expression of retinoic acid-inducible gene-I (RIG-I) and melanoma differentiation-associated gene 5 (MDA5) in differentiated human podocytes in culture.
MATERIALS AND METHODS METHODS
The podocytes were treated with 2 ng/ml to 500 μg/ml of polyIC for 3 to 36 h, and also transfected with siRNA against RIG-I and MDA5. F-actin staining was performed to assess actin reorganization.
RESULTS RESULTS
PolyIC induced the expression of RIG-I and MDA5 in dose- and time-dependent manner, accompanied with interferon-β (IFN-β) and interleukin-6 (IL-6) up-regulation and actin reorganization. Temporal knockdown of RIG-I by siRNA decreased IFN-β expression, while MDA5 siRNA inhibited IFN-β and IL-6 expression. Actin reorganization was attenuated by RIG-I and MDA5 knockdown.
CONCLUSION CONCLUSIONS
RIG-I and MDA5 may play a role in the antiviral responses of podocytes.

Identifiants

pubmed: 33402460
pii: 35/1/147
doi: 10.21873/invivo.12242
pmc: PMC7880774
doi:

Substances chimiques

Tretinoin 5688UTC01R
DEAD Box Protein 58 EC 3.6.4.13
DEAD-box RNA Helicases EC 3.6.4.13
Interferon-Induced Helicase, IFIH1 EC 3.6.4.13

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

147-153

Informations de copyright

Copyright© 2021, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Références

J Am Soc Nephrol. 2009 Feb;20(2):260-6
pubmed: 19056875
Nat Clin Pract Nephrol. 2006 May;2(5):254-62
pubmed: 16932438
Cell. 2010 Mar 19;140(6):805-20
pubmed: 20303872
Am J Pathol. 2006 Feb;168(2):370-85
pubmed: 16436653
Nephrol Dial Transplant. 2009 Nov;24(11):3312-8
pubmed: 19608629
Nephrol Dial Transplant. 2010 Nov;25(11):3534-9
pubmed: 20484300
Immunity. 2011 May 27;34(5):637-50
pubmed: 21616434
Nephrol Dial Transplant. 2012 Jan;27(1):81-9
pubmed: 21617192
Pediatr Nephrol. 2017 Aug;32(8):1355-1361
pubmed: 28210837
Eur J Immunol. 2007 Dec;37(12):3582-6
pubmed: 18034431
Cell Host Microbe. 2009 Aug 20;6(2):150-61
pubmed: 19683681
J Clin Invest. 2004 May;113(10):1390-7
pubmed: 15146236
J Nephrol. 2013 Sep-Oct;26(5):886-93
pubmed: 23559071
Nephrol Dial Transplant. 2013 Jun;28(6):1439-46
pubmed: 23262434
Cell. 2006 Feb 24;124(4):783-801
pubmed: 16497588
Am J Pathol. 2009 Nov;175(5):2014-22
pubmed: 19850889
Kidney Int. 2010 Apr;77(7):571-80
pubmed: 19924101
Front Immunol. 2019 Jul 17;10:1586
pubmed: 31379819

Auteurs

Masamichi Nakata (M)

Department of Cardiology and Nephrology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.

Michiko Shimada (M)

Department of Cardiology and Nephrology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan; mshimada@hirosaki-u.ac.jp.

Ikuyo Narita-Kinjo (I)

Department of Cardiology and Nephrology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.

Daiki Nagawa (D)

Department of Cardiology and Nephrology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.

Kazutaka Kitayama (K)

Department of Cardiology and Nephrology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.

Misato Hamadate (M)

Department of Cardiology and Nephrology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.

Naotake Miura (N)

Department of Cardiology and Nephrology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.

Masashi Nozaka (M)

Department of Cardiology and Nephrology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.

Yosuke Kawamura (Y)

Department of Cardiology and Nephrology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.

Takeshi Fujita (T)

Department of Cardiology and Nephrology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.

Reiichi Murakami (R)

Department of Cardiology and Nephrology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.

Tadaatsu Imaizumi (T)

Department of Vascular Biology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.

Norio Nakamura (N)

Community Medicine, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.

Hirofumi Tomita (H)

Department of Cardiology and Nephrology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH